Real-time enrollment status for this locally advanced or metastatic malignant solid tumors clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 9:54 PM UTC
| NCT Number | NCT07287995 |
| Recruiting Status | Recruiting |
| Condition | Locally Advanced or Metastatic Malignant Solid Tumors |
| Phase | PHASE1 |
| Target Enrollment | 428 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Astellas Pharma Global Development, Inc. |
| Last Updated on CT.gov | June 10, 2026 (Jun 10, 2026) |
As of August 31, 2026: Clinical trial NCT07287995 is currently recruiting participants. This phase1 study for locally advanced or metastatic malignant solid tumors is actively seeking new participants at 4 locations across the United States. The study is sponsored by Astellas Pharma Global Development, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07287995 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07287995 was last updated Jun 10, 2026 (June 10, 2026). HelloStudys verifies this status automatically.